These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 25974899)

  • 1. Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.
    Angulo P; Machado MV; Diehl AM
    Semin Liver Dis; 2015 May; 35(2):132-45. PubMed ID: 25974899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Kaswala DH; Lai M; Afdhal NH
    Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research.
    Berardo C; Di Pasqua LG; Cagna M; Richelmi P; Vairetti M; Ferrigno A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
    Schild MH; Guy CD
    Surg Pathol Clin; 2018 Jun; 11(2):267-285. PubMed ID: 29751874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.
    Bedossa P; Patel K
    Gastroenterology; 2016 Jun; 150(8):1811-1822.e4. PubMed ID: 27003601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Natural Course of Non-Alcoholic Fatty Liver Disease.
    Calzadilla Bertot L; Adams LA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.
    Haas JT; Francque S; Staels B
    Annu Rev Physiol; 2016; 78():181-205. PubMed ID: 26667070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.
    Patel V; Sanyal AJ; Sterling R
    Clin Liver Dis; 2016 May; 20(2):277-92. PubMed ID: 27063269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological features of fatty liver disease.
    Yeh MM; Brunt EM
    Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
    Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?
    Aggarwal A; Puri K; Thangada S; Zein N; Alkhouri N
    Curr Pediatr Rev; 2014; 10(2):151-61. PubMed ID: 25088269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.
    Dyson JK; McPherson S; Anstee QM
    Postgrad Med J; 2014 May; 90(1063):254-66. PubMed ID: 24737902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural History of Nonalcoholic Fatty Liver Disease.
    Goh GB; McCullough AJ
    Dig Dis Sci; 2016 May; 61(5):1226-33. PubMed ID: 27003142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease: diagnosis and investigation.
    Nascimbeni F; Loria P; Ratziu V
    Dig Dis; 2014; 32(5):586-96. PubMed ID: 25034292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic parenchimatous damage and perfusion disturbance in the progression of nonalcoholic fatty liver disease].
    Dudanova OP; Belavina IA
    Eksp Klin Gastroenterol; 2014; (8):41-5. PubMed ID: 25911911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
    Almeda-Valdes P; Aguilar Olivos NE; Barranco-Fragoso B; Uribe M; Méndez-Sánchez N
    Biomed Res Int; 2015; 2015():768071. PubMed ID: 26339640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
    Siddiqui MS; Charlton M
    Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
    Fierbinteanu-Braticevici C; Sinescu C; Moldoveanu A; Petrisor A; Diaconu S; Cretoiu D; Braticevici B
    Cell Biol Toxicol; 2017 Feb; 33(1):5-14. PubMed ID: 27680752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Lassailly G; Caiazzo R; Pattou F; Mathurin P
    Gastroenterology; 2016 Jun; 150(8):1835-48. PubMed ID: 26971824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.